Development of a CRISPR-Cas13-based antiviral strategy against hepatitis E virus
Background & Aims: Effective antiviral drugs remain unavailable for many clinically relevant pathogens, including the hepatitis E virus (HEV). This study aimed to evaluate the CRISPR/Cas13d system as a potential antiviral strategy against HEV. Methods: We developed a reporter assay to screen CRI...
Na minha lista:
| Principais autores: | , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Elsevier
2026-07-01
|
| Serier: | JHEP Reports |
| Fag: | |
| Online adgang: | http://www.sciencedirect.com/science/article/pii/S2589555926001564 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
